Current Resident
Alexis Jeschonnek
I am originally from Reading, PA and moved back closer to home after receiving my PharmD from the University of Pittsburgh School of Pharmacy. During pharmacy school, I worked as a pharmacy intern at Weis Markets Pharmacy in the Lancaster and Reading areas. I then went on to complete my PGY1 pharmacy residency at Penn Medicine Lancaster General Health and am very happy to continue my training here as the PGY2 Ambulatory Care Pharmacy Resident. My current pharmacy areas of interest are cardiology and diabetes. In my free time, I enjoy spending time with my friends and family, going on hikes with my dog, and trying new restaurants.
Major Research Project: A Review of the Risk of Genitourinary Infections with SGLT-2 inhibitors at HgbA1c levels greater than 9%
Medication Use Evaluation: Evaluation of LDL-C goal achievement in patients with clinical atherosclerotic cardiovascular disease
Grand Rounds: There's always Rheum at the top! An overview of the use of DMARDs in rheumatoid arthritis
Graduate Residents
Meredith Clark
Pharmacy School: Jefferson College of Pharmacy in Philadelphia
PGY1 Residency: Pharmacy Practice Residency, Lancaster General Health
Position upon completion of program: Specialty Clinical Pharmacist at Penn State Hershey Medical Center
Location: Lancaster General Health
Major Research Project: Evaluation of Acetylcholine Esterase Inhibitors and Memantine Deprescribing
Medication Use Evaluation: Evaluation of appropriate use of hormone replacement therapy
Ground Rounds:Perioperative management of antihyperglycemic medications
Alexander Haines
Pharmacy School: Temple University School of Pharmacy
PGY1 Residency: Pharmacy Practice Residency, Lancaster General Health
Position upon completion of program: Specialty Clinical Pharmacist at Penn State Hershey Medical Center
Major Research Project: Evaluation of Acetylcholine Esterase Inhibitors and Memantine Deprescribing
Medication Use Evaluation: Lehigh Valley Health Network
Ground Rounds: There’s “NASH-ing” To It&mdashPharmacotherapy Considerations for Nonalcoholic Fatty Liver Disease (NAFLD) & Nonalcoholic Steatohepatitis (NASH)
Brian Foster
Pharmacy School:University of Rhode Island College of Pharmacy
PGY1 Residency:Pharmacy Practice Residency, Lancaster General Health
Position upon completion of program:Heart failure Clinical Pharmacy Specialist
Location:Lehigh Valley Health Network
Major Research Project:Evaluation of Osteoporosis Treatment in Patients Treated with Raloxifene
Medication Use Evaluation:Optimizing Medication Therapy and Outcomes for Patients with Diabetes and Heart Failure
Grand Rounds:The Clot Thickens: Pharmacotherapy Review of Anticoagulation in Liver Disease
Carrie Clutter
Pharmacy School: West Virginia University School of Pharmacy
PGY1 Residency: Pharmacy Practice Residency, Lancaster General Health
Position upon completion of program: Ambulatory Care Clinical Pharmacist
Location: West Virginia University Medicine
Major Research Project: Role of the pharmacist in the transition of care between an endocrinology specialist medical practice back to primary care
Medication Use Evaluation:Evaluation of the usage of inhaled corticosteroids in patients with chronic obstructive pulmonary disease in the primary care setting
Grand Rounds: Latent Autoimmune Diabetes in Adults (LADA): Is Insulin the Only Option?
Mara Wilson
Pharmacy School: Wilkes University, Nesbitt School of Pharmacy
PGY1 Residency: Pharmacy Practice Residency, Lancaster General Health
Position upon completion of program: Ambulatory Care Clinical Pharmacist
Location: Lancaster General Health
Major Research Project: Social determinants of glycemic control
Medication Use Evaluation: Identification of patients on anticoagulation who are eligible to transition from traditional warfarin therapy to direct oral anticoagulant therapy
Grand Rounds: Analysis of Cardiovascular Outcomes with Glucagon Like Peptide-1 Receptor Agonists